The effects of Eclipta Prostrata L.(Ecliptae Herba) on periodontitis rats

Article information

J Korean Med. 2018;39(1):63-74

Publication date (electronic) : 2018 March 31

doi : https://doi.org/10.13048/jkm.18007

Jun Hyuk Park

, Haesu Lee

, Woong Mo Yang

Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University

Correspondence to: 양웅모 (Woong Mo Yang), 서울시 동대문구 회기동 1번지 경희대학교한의과대학, Tel: +82-2-961-2209, E-mail: wmyang@khu.ac.kr

Received 2017 November 20; Revised 2018 March 7; Accepted 2018 March 26.

Abstract

Objectives

Periodontitis is an inflammatory disease with the destruction of periodontal ligament, alveolar bone loss and inflammation of gingva, leading to teeth loss. Eclipta prostrata L. (Ecliptae Herba) has been used to treat the inflammatory disease as a Korean traditional medicine. The aim of this study is to investigate the effects of E. prostrata L. on periodontitis.

Methods

E. prostrata L. was extracted with water and lyophilized. The aqueous extract of E. prostrata L. (EP) was topically applied to the periodontal lesion for 2 weeks. To induce the periodontitis, a 3-0 nylon ligature was placed around the cervix of the lower first molar in rat. Rats were divided into 3 groups (n = 7); NL group (non-ligatured and non-treated), L group (ligatured and vehicle-treated) and EP group (ligatured and EP-treated). After sacrifice, the mandibles was dissected and stained with methylene blue solution to analyze the alveolar bone loss. The expression of MMP-9 was determined in gingival tissues. To confirm the effect of EP on recovery of gingiva, mRNA expressions of type I pro-collagen and MMP-9 levels were investigated in LPS-treated HS68 fibroblast cells. In addition, inflammatory mediators were evaluated in LPS-treated RAW264.7 cells.

Results

Alveolar bone loss was significantly inhibited by EP treatment. The mRNA expression of MMP-9 was attenuated in rats treated with EP. In addition, treatment with EP increased the expression of type I pro-collagen, while the expression of MMP-9 was decreased in LPS-stimulated HS68 fibroblast cells. Furthermore, EP down-regulated the LPS-induced IL-6, TNF-α, COX-2 and iNOS production in RAW264.7 cells.

Conclusions

These results suggest that EP have ameliorative effects on periodontitis through inhibiting alveolar bone loss and modulating the inflammatory mediators. Therefore, E. prostrata L. may be an alternative on patients with periodontitis.

Keywords: Eclipta prostrata L.; periodontitis; MMP-9; collagen; inflammation

Fig. 1

Experimental design for induction of periodontitis.

Ligature was placed around the cervix of the bilateral mandibular first molars of rats.

Fig. 2

Effects of EP on alveolar bone loss. (A) Representative images and (B) quantified values of alveolar bone loss. The red lines represent the distance from the cementoenamel junction to the alveolar bone crest. ^###p < 0.001 vs. NL; **p < 0.01 vs. L. NL, non-ligatured and non-treated; L, ligatured and vehicle-treated; EP, ligatured and Eclipta prostrata-treated.

Fig. 3

Effects of EP on the MMP-9 expression in gingival tissues. GAPDH has been used as loading control. ^###p < 0.001 vs. NL; ***p < 0.001 vs. L. NL, non-ligatured and non-treated; L, ligatured and vehicle-treated; EP, ligatured and Eclipta prostrata-treated.

Fig. 4

Effects of EP on the expressions of type I pro-collagen and MMP-9 in LPS-stimulated HS68 fibroblast cells.

(A) Type I pro-collagen and (B) MMP-9 expressions. GAPDH has been used as loading control. ^###p < 0.001 vs. normal; ***p < 0.001 or *p < 0.05 vs. LPS. EP; Eclipta prostrata L. extract.

Fig. 5

Effects of EP on the expressions of IL-6 and TNF-α in LPS-stimulated RAW264.7 macrophage cells. (A) IL-6 and (B) TNF-α expressions. ^###p < 0.001 vs. normal; ***p < 0.001 vs. LPS. EP; Eclipta prostrata L. extract.

Fig. 6

Effects of EP on the expressions of iNOS and COX-2 in LPS-stimulated RAW264.7 macrophage cells. (A) iNOS and (B) COX-2 expressions. β-actin has been used as loading control. ^###p < 0.001 vs. normal; ***p < 0.001 vs. LPS; *p < 0.05 vs. LPS. EP; Eclipta prostrata L. extract.

Table 1

RT-PCR Sequence of Target Designed by the Software of Applied Bioscience Prism 7000 System.

References

1. Petersen PE, Ogawa H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontology 2000 2012;60(1):15–39.

2. Renvert S, Persson GR. A systematic review on the use of residual probing depth, bleeding on probing and furcation status following initial periodontal therapy to predict further attachment and tooth loss. Journal of clinical periodontology 2002;29(3):82–89.

3. Korea National Health and Nutrition Examination Survey Ministry of Health, Welfare and Family Affairs; 2015.

4. Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontology 2000 2013;62(1):203–217.

5. Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontology 2000 1994;5(1):7–25.

6. Boyce BE, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, et al. TNF-α and pathologic bone resorption. The Keio journal of medicine 2005;54(3):127–131.

7. Apatzidou DA, Kinane DF. Nonsurgical mechanical treatment strategies for periodontal disease. Dental Clinics of North America 2010;54(1):1–12.

8. Winkelhoff AJV, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontology 2000 1996;10(1):45–78.

9. Quirynen M, Teughels W, Soete MD, Steenberghe DV. Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects. Periodontology 2000 2002;28(1):72–90.

10. Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics. Dental research journal 2012;9(5):505.

11. Heo J. Donguibogam 1st edth ed. Seoul: Bubinmunhwasa; 1999. p. 617–632.

12. Editing commission of herbal medicine. Herbal medicine 1st edth ed. Seoul: Youngrimsa; 2010. p. 658.

13. Yuan F, Chen J, Sun PP, Guan S, Xu J. Wedelolactone inhibits LPS-induced pro-inflammation via NF-κB pathway in RAW264.7 cells. Journal of biomedical science 2013;20(1):84.

14. Arunachalam G, Subramanian N, Pazhani GP, Ravichandran V. Anti-inflammatory activity of methanolic extract of Eclipta prostrata L (Astearaceae). African journal of pharmacy and pharmacology 2009;3(3):097–100.

15. Tewtrakul S, Subhadhirasakul S, Tansakul P, Cheenpracha S, Karalai C. Antiinflammatory constituents from Eclipta prostrata using RAW 264. 7 macrophage cells. Phytotherapy research 2011;25(9):1313–1316.

16. Kim MH, Choi YY, Lee HJ, Lee HS, Park JC, Yang WM. Topical application of herbal formula for the treatment of ligature-induced periodontitis. Journal of periodontal & implant science 2015;45(4):145–151.

17. Lohinai Z, Benedek P, Feher E, Gyor A, Rosival F, Fazeka IA, et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. British journal of pharmacology 1998;123(3):353–360.

18. Mine T, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ. The relationship between bone mineral density and periodontitis in postmenopausal women. Journal of Periodontology 2000;71(9):1492–1498.

19. Makela M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. Journal of dental research 1994;73(8):1397–1406.

20. Marcaccini AM, Novaes AB Jr, Meschiari CA, Souza SL, Palioto DB, Sorgi CA, et al. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clinica Chimica Acta 2009;409(1):117–122.

21. Elavarasu S, Sekar S, Murugan T. Host modulation by therapeutic agents. Journal of pharmacy & bioallied sciences 2012;4(Suppl 2):S256.

22. Choi DH, Moon IS, Choi BK, Paik JW, Kim YS, Choi SH, et al. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. Journal of periodontal research 2004;39(1):20–26.

23. Paul B, Sage H. Structurally distinct collagen types. Annual review of biochemistry 1980;49(1):957–1003.

24. Bumann A, Carvalho RS, Schwarzer CL, Yen EHK. Collagen synthesis from human PDL cells following orthodontic tooth movement. European journal of orthodontics 1997;19(1):29–37.

25. Böhl MV, Maltha J, Hoff HVD, Muijpers-jagtman AM. Changes in the periodontal ligament after experimental tooth movement using high and low continuous forces in beagle dogs. The Angle orthodontist 2004;74(1):16–25.

26. Havemose-Poulsen A, Holmstrup P, Stoltze K, Birkedal-Hansen H. Dissolution of type I collagen fibrils by gingival fibroblasts isolated from patients of various periodontitis categories. Journal of periodontal research 1998;33(3):280–291.

27. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Critical Reviews in Oral Biology & Medicine 1998;9(3):248–266.

28. Nibali L, Fedele S, Daiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral diseases 2012;18(3):236–243.

29. Matsuda Y, Katoo T, Takahashi N. Ligature-induced periodontitis in mice induces elevated levels of circulating interleukin-6 but shows only weak effects on adipose and liver tissues. Journal of periodontal research 2016;51(5):639–646.

30. Geivelis M, Turner DW, Pederson ED, Lamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. Journal of periodontology 1993;64(10):980–983.

31. Rossomando EF, Kennedy JE, Hadjimichael J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Archives of oral biology 1990;35(6):431–434.

32. Boyce BE, Li P, Yao Z, Zhang Q, Badell IR, Schwarz EM, et al. TNF-α and pathologic bone resorption. The Keio journal of medicine 2005;54(3):127–131.

33. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-κB in the resolution of inflammation. Nature medicine 2001;7(12):1291–1297.

34. Moncada S, Palmer RML, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological reviews 1991;43(2):109–142.

35. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. Annual review of immunology 1997;15(1):323–350.

36. Tunctan B, Uluda O, Altu S, Abacio N. Effects of nitric oxide synthase inhibition in lipopolysaccharide -induced sepsis in mice. Pharmacological research 1998;38(5):405–411.

37. Daghigh F, Borghaei RC, Thornton RD, Bee JH. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. Journal of periodontology 2002;73(4):392–400.

38. Lohinai Z, Stachlewitz R, Virag L, Szekely AD, Hasko G, Szabo C. Evidence for reactive nitrogen species formation in the gingivomucosal tissue. Journal of dental research 2001;80(2):470–475.

39. Morton RS, Dongari-Bagtzoglou AI. Cyclooxygenase-2 is upregulated in inflamed gingival tissues. Journal of periodontology 2001;72(4):461–469.

40. Holzhausen M, Rossa C Jr, Marcantonio E Jr, Nassar PO, Spolidorio DMP, Spolidorio LC. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. Journal of periodontology 2002;73(9):1030–1036.

Article information Continued